RIO DE JANEIRO (Reuters) – Brazil health regulator Anvisa on Wednesday said it approved emergency use of the COVID-19 vaccine developed by Johnson & Johnson subsidiary Janssen.
(Reporting by Pedro Fonseca)
Brazil health regulator approves emergency use of Johnson & Johnson COVID-19 vaccine
Mar 31, 2021 | 1:44 PM
